Savvy HOT NEWS, 1/24/23: Tidepool Announces FDA Clearance of Tidepool Loop
Tidepool, a 501(c)3 nonprofit committed to empowering the next generation of innovations in diabetes management, today announced the FDA clearance of Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in persons six...
Savvy Updates, 1/23/23:FDA Approves Mallya Smart Pen, T1D’s 6 Hormones, Inaccurate A1c Results, Fasting Diets, Diabetic Macular Edema, Healthcare Company Bankruptcies Up 84%
FDA Clears Smart Injector Pen Device by Andrew Briskin for diaTribe.org, 17 January 2023. In December 2022, the FDA cleared Mallya, a smart sensor that attaches directly to insulin pen injectors, turning a disposable pen into a smartphone-connected...
Savvy Updates 1/16/23: CGM $$$, Insulin Pill Fails, Med School & AI, DIY Loop 3.0, 5-Minute Walks, T1D Kids & School Days
CGM is BIG MONEY!!! How Abbott plans to make its Freestyle Libre a $10B product by Elise Reuter for MedTechDive.com, 10 January 2023. CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors and its broader diabetes...
Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System in a press release on NewsWire.com, 4 January 2023. Caution: The iLet Bionic Pancreas is an investigational device...
Savvy Updates, 1/2/23: Ozempic Shortages, Artificially Sweetened Drinks & Incontinence, Worldwide Surge in Diabetes, FDA Regulating Practice of Medicine, Happy New Year
Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages by Nicole DeFeudis for EndPoints.com, 13 December 2022. On the heels of Wegovy supply troubles, Novo Nordisk is reporting a shortage of its diabetes treatment Ozempic which contains...
More Diabetes Blogs